.png){kind=logo}
A reusable smart insulin pen that uses Bluetooth® to send data to an app, making it easier to track insulin doses and manage your diabetes.
Less guesswork, more support with Smart MDI
Get personalized dosing guidance with the new InPenTM smart insulin pen with SimpleraTM CGM.†
Actionable insights with Smart MDI
For people who manage their diabetes with multiple daily injections (MDI), this system can help relieve the mental effort that comes with regular insulin injections.
Integrating our new SimpleraTM CGM, InPenTM smart insulin pen, and an intuitive app, this Smart MDI system provides you with:
- Personalized dosing recommendations
- Missed meal dose alerts
- High glucose correction notifications
- Dose calculator
Smart MDI system components
InPenTM smart insulin pen
InPenTM smart insulin pen
Continuous glucose monitor (CGM)
Continuous glucose monitor (CGM)
Sensors measure and send sugar levels to the pump. We have all-in-one disposable CGM options. See options.
.png)
Infusion set
Infusion set
Allows for continuous and discreet delivery of insulin through a thin, flexible tube. Get up to 7 days of wear time with the Medtronic ExtendedTM infusion set.
Footnotes
† Products sold separately.
Important Safety Information: InPen system
The InPen system consists of a reusable insulin pen and mobile app and is for people living with diabetes. It can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals. Those under the age of 7 should only use the device with an adult’s supervision. A healthcare provider must prescribe InPen, provide dosage settings, and discuss all potential benefits and risks. Using the device with incorrect therapy settings may lead to severe highs and lows. The system should not be used by those unable to test blood glucose levels or the visually impaired. For additional product and important safety information, see https:www.minimed.com/en-us/important-safety-information.html#smart-pen-system
Important Safety Information: SimpleraTM system
The SimpleraTM system requires a prescription. It consists of a sensor and mobile app that perform real-time continuous glucose monitoring (CGM) for the management of diabetes in adults ages 18 years and older. The sensor is indicated for up to 6 days of use, plus an additional grace period of 24 hours. It is intended for use in home environments. The Simplera™ system does not require calibration. Blood glucose (BG) readings are required (1) during the first 12 hours of use, (2) if no sensor data is available, (3) when symptoms do not match the sensor glucose (SG) value, and (4) when taking certain medications. Not taking BG readings as indicated can lead to incorrect SG readings, over-administration of insulin, and possible hypoglycemia.
The SimpleraTM app in combination with the Simplera™ sensor is intended for use only by patients and caregivers using a compatible mobile device and operating system, and who have sufficient experience to adjust mobile device audio and notification settings. When taking any of the following medications, consult a healthcare professional prior to using the system, as these can bias SG readings, potentially leading to the over-administration of insulin and a higher risk of hypoglycemia: acetaminophen, paracetamol, hydroxyurea, hydroxycarbamide. Sensor use can also result in skin irritation, bruising, discomfort, redness, bleeding, and infection, and sensors in general also pose a choking risk to young children. For complete details, consult the user guides and important safety information.